Trabectedin Reduces Skeletal Prostate Cancer Tumor Size in Association with Effects on M2 Macrophages and Efferocytosis by J.D. Jones, B.P. Sinder, D. Paige, F.N. Soki, A.J. Koh, S. Thiele, Y. Shiozawa, L.C. Hofbauer, S. Daignault, H. Roca, L.K. McCauley

Get full text

A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial by K. Hoyer, R. Hablesreiter, Y. Inoue, K. Yoshida, F. Briest, F. Christen, N. Kakiuchi, T. Yoshizato, Y. Shiozawa, Y. Shiraishi, J.K. Striefler, S. Bischoff, P. Lohneis, H. Putter, O. Blau, U. Keilholz, L. Bullinger, U. Pelzer, M. Hummel, H. Riess, S. Ogawa, M. Sinn, F. Damm

Get full text

P744: UNBALANCED TRANSLOCATION DER(1;7)(Q10;P10) AS A DISTINCT SUBTYPE IN MYELODYSPLASTIC SYNDROMES by R. Okuda, Y. Ochi, K. Chonabayashi, N. Hiramoto, M. Sanada, H. Handa, S. Kasahara, S. Sato, N. Kanemura, T. Kitano, M. Watanabe, W. Kern, M. Creignou, Y. Shiraishi, M. Watanabe, K. Usuki, S. Imashuku, E. Hellstrom-Lindberg, T. Haferlach, S. Chiba, N. Sezaki, L.-Y. Shih, Y. Miyazaki, Y. Yoshida, T. Ishikawa, K. Ohyashiki, Y. Atsuta, Y. Shiozawa, S. Miyano, H. Makishima, Y. Nannya, S. Ogawa

Get full text

P741: DDX41 MUTATIONS DEFINE A UNIQUE SUBTYPE OF MYELOID NEOPLASMS. by H. Makishima, R. Saiki, Y. Nannya, S. Korotev, C. Gurnari, J. Takeda, Y. Momozawa, S. Best, P. Krishnamurthy, T. Yoshizato, Y. Atsuta, Y. Shiozawa, Y. Iijima-Yamashita, K. Yoshida, Y. Shiraishi, Y. Nagata, N. Kakiuchi, M. Onizuka, K. Chiba, H. Tanaka, A. Kon, Y. Ochi, M. Nakagawa, R. Okuda, T. Mori, H. Itonaga, Y. Miyazaki, M. Sanada, H. Tsurumi, S. Kasahara, C. Müller-Tidow, A. Takaori-Kondo, K. Ohyashiki, T. Kiguchi, F. Matsuda, J. Jansen, C. Polprasert, S. Miyano, L. Malcovati, T. Haferlach, M. Kubo, M. Cazzola, A. Kulasekararaj, L. Godley, J. Maciejewski, S. Ogawa

Get full text